Positions

Overview

  • Introduction:

    Dr. Gangaraju comes to our division from the University of Utah and Huntsman Cancer Institute, Salt Lake City, where she completed a Fellowship in Hematology and Oncology and conducted research with Dr. Josef Prchal, a former UAB Hematology member. Originally from India, Dr. Gangaraju received her Bachelors in Medicine and Bachelors in Surgery (M.B.B.S.) degrees from Rangaraya Medical College, Andhra Pradesh. She completed an Internal Medicine Residency in the UAB Montgomery program from 2010-13 and a Fellowship in Blood Banking and Transfusion Medicine at UAB Birmingham from 2013-14.

    Clinical Interests:

    Dr. Gangaraju will provide specialized care to patients diagnosed with coagulation disorders, non-malignant hematological disorders, myeloproliferative neoplasms, and sickle cell disease. She will see patients at The Kirklin Clinic and participate in the Hematology and Oncology consult service.

    Research:

    Thrombotic and hemostatic complications of cancer and cancer treatments.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Race, rituximab, and relapse in TTP.  Blood.  140:1335-1344. 2022
    2022 Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.  Cancer.  128:2348-2357. 2022
    2022 Erratum: TEMPORARY REMOVAL: PO-07: Procoagulant extracellular vesicles in patients with different types of acute leukemia (Thrombosis research PII: S0049-3848(22)00195-5).  Thrombosis Research: vascular obstruction, hemorrhage and hemostasis.  213:S14. 2022
    2022 Congenital and acquired disorders of secondary hemostasis 2022
    2022 From Activated Partial Thromboplastin Time to Antifactor Xa and Back Again.  American Journal of Clinical Pathology.  157:321-327. 2022
    2021 Questioning the association between ABO type and outcomes in patients with COVID-19.  Annals of Hematology.  100:3081-3082. 2021
    2021 Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: A BMTSS-HiGHS2 risk model.  Blood Advances.  5:4102-4111. 2021
    2021 Peripheral blood cytopenia and risk of cardiovascular disease and mortality.  Journal of the American Heart Association.  10. 2021
    2021 Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy.  Journal of Thrombosis and Haemostasis.  19:2068-2081. 2021
    2021 High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group.  Blood Cancer Journal.  11. 2021
    2021 Venous-thromboembolism in elderly patients with acute myeloid leukemia.  Thrombosis Research: vascular obstruction, hemorrhage and hemostasis.  200:9-11. 2021
    2020 Advanced therapies and extracorporeal membrane oxygenation for the management of high-risk pulmonary embolism.  Hematology online (ASH).  20:195-200. 2020
    2020 Current Practice and Clinical Utility of Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke.  Journal of Stroke and Cerebrovascular Diseases.  29. 2020
    2020 Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia.  Blood Advances.  4:1115-1130. 2020
    2019 Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.  Blood Advances.  3:4177-4186. 2019
    2019 Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.  Cancer.  125:4498-4508. 2019
    2019 Response to interferon treatment in essential thrombocythemia with inv(3)(q21q26).  Annals of Hematology.  98:2845-2846. 2019
    2019 Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study.  Biology of Blood and Marrow Transplantation.  25:2261-2266. 2019
    2019 Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study.  British Journal of Haematology.  186:367-370. 2019
    2019 In Reply:.  Cleveland Clinic Journal of Medicine.  86:368-368. 2019
    2019 Three neglected numbers in the CBC: The RDW, MPV, and NRBC count.  Cleveland Clinic Journal of Medicine.  86:167-172. 2019
    2019 Fat embolism syndrome due to bone marrow necrosis in patients with hemoglobinopathies: A life-threatening complication mimicking thrombotic thrombocytopenic purpura.  American Journal of Hematology.  94:E64-E66. 2019
    2019 Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura.  Haematologica: the hematology journal.  104:166-175. 2019
    2019 Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials.  Oncology Reviews.  13:170-174. 2019
    2019 Revisiting fat embolism in sickle syndromes: diagnostic and emergency therapeutic measures.  British Journal of Haematology.  186:e112-e115. 2019
    2017 Rare complication of treated immune thrombocytopenia.  American Journal of Hematology.  92:1262-1266. 2017
    2017 An Unusual Presentation of Thrombotic Thrombocytopenic Purpura.  American Journal of Medicine.  130:e323-e326. 2017
    2017 Thrombotic Thrombocytopenic Purpura Associated With Pegylated Interferon Alfa-2a Use in a Patient With Polycythemia Vera.  Journal of the National Comprehensive Cancer Network : JNCCN.  15:757-760. 2017
    2017 Regulation of erythropoiesis after normoxic return from chronic sustained and intermittent hypoxia.  Journal of Applied Physiology.  123:1671-1675. 2017
    2016 Upshaw-Schulman syndrome and pregnancy: successful management with plasma infusions.  Annals of Hematology.  95:1745-1746. 2016
    2016 Fat embolism syndrome secondary to bone marrow necrosis in patients with hemoglobinopathies.  Southern Medical Journal.  109:549-553. 2016
    2015 An unusual case of near-fatal hemolytic anemia treated with erythrocytapheresis and therapeutic plasma exchange.  Transfusion.  55:475. 2015
    2015 Adverse Effects of Transfusion.  Cancer Control : Journal of the Moffitt Cancer Center.  22:16-25. 2015
    2014 Perplexity of a fungus in the sinus.  American Journal of Medicine.  127:e1. 2014
    2013 Primary adrenal lymphoma with paraneoplastic syndrome.  North American Journal of Medical Sciences.  5:721-723. 2013
    2013 Heparin induced thrombocytopenia: Review.  Expert Review of Hematology.  6:419-428. 2013
    2013 Current advances in understanding and managing secondary brain metastasis.  CNS Oncology.  2:75-85. 2013

    Education And Training

  • University of Alabama at Birmingham, Internship
  • University of Alabama at Birmingham, Residency
  • University of Alabama at Birmingham, Postdoctoral Fellowship
  • University of Utah, Postdoctoral Fellowship
  • Bachelor of Medicine & Surgery (MBBS), NTR University of Health Sciences Andhra Pradesh 2005

    • Full Name

  • Radhika Gangaraju